|
|
|
|
Comparison of Renal Outcomes by Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) Containing Regimens for
Prevention, and Treatment of HIV and/or HBV Treatment: A Systematic Literature Review and Meta-Analysis
|
|
|
IDWeek; October 16-19, 2024; Los Angeles, CA, USA
Xi Liang1, Kyu Yun Park1, Haeseon Lee1, Connor Willis1, Tara Dhippayom2, Rachel Rogers4, Amy R. Weinberg4,
Julia Green4, Aileen Chi4, Nathorn Chaiyakunapruk1,3
1Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA; 2The
Prince Royal's College, Chiang Mai, Thailand; 3IDEAS Center, Veterans Affairs Salt Lake City Healthcare System,
Salt Lake City, Utah, USA; 4Gilead Sciences, Foster City, CA, USA
|
|
|
|
|
|
|